Orthotopic transplantation patients hepatitis virus-related liver disease Fifty-nine patients prior hepatitis virus infection underwent orthotopic liver transplantation first mo mortality different hepatitis virus-infected group hepatitis virus-immune control group mo mortality rate graft loss retransplantation incidence abnormal liver function hepatitis virus-infected group Treatment hepatitis virus infection passive immunization active passive immunization alpha-interferon nothing clinical outcome therapies patients days treated active passive immunization HBsAg something patients alpha-interferon patients passive immunization patients therapy patients recurrent hepatitis virus infection pace hepatitis development graft striking patients multiple retransplantations shorter intervals None patients HBsAg-negative HBeAg 